- Home
- POAI vs MIRM Comparison
POAI vs MIRM Comparison
Compare POAI & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- MIRM
- Stock Information
- Founded
- POAI 2002
- MIRM 2018
- Country
- POAI United States
- MIRM United States
- Employees
- POAI 35
- MIRM N/A
- Industry
- POAI Industrial Specialties
- MIRM Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- MIRM Health Care
- Exchange
- POAI Nasdaq
- MIRM Nasdaq
- Market Cap
- POAI 9.9M
- MIRM N/A
- IPO Year
- POAI N/A
- MIRM 2019
- Fundamental
- Price
- POAI $1.25
- MIRM $42.15
- Analyst Decision
- POAI Hold
- MIRM Strong Buy
- Analyst Count
- POAI 1
- MIRM 11
- Target Price
- POAI N/A
- MIRM $58.55
- AVG Volume (30 Days)
- POAI 8.1M
- MIRM 458.0K
- Earning Date
- POAI 05-13-2025
- MIRM 05-07-2025
- Dividend Yield
- POAI N/A
- MIRM N/A
- EPS Growth
- POAI N/A
- MIRM N/A
- EPS
- POAI N/A
- MIRM N/A
- Revenue
- POAI $1,623,817.00
- MIRM $336,888,000.00
- Revenue This Year
- POAI $486.27
- MIRM $29.54
- Revenue Next Year
- POAI $65.50
- MIRM $20.52
- P/E Ratio
- POAI N/A
- MIRM N/A
- Revenue Growth
- POAI N/A
- MIRM 80.76
- 52 Week Low
- POAI $0.55
- MIRM $23.14
- 52 Week High
- POAI $3.06
- MIRM $54.23
- Technical
- Relative Strength Index (RSI)
- POAI 48.03
- MIRM 35.33
- Support Level
- POAI $1.26
- MIRM $45.61
- Resistance Level
- POAI $1.58
- MIRM $45.66
- Average True Range (ATR)
- POAI 0.21
- MIRM 1.78
- MACD
- POAI 0.01
- MIRM -0.26
- Stochastic Oscillator
- POAI 16.13
- MIRM 8.81
Stock Price Comparison Chart: POAI vs MIRM
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.